Amphastar Pharmaceuticals downgraded by Piper Sandler with a new price target

2/4/25 6:58:07 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Piper Sandler downgraded Amphastar Pharmaceuticals from Overweight to Neutral and set a new price target of $36.00 from $66.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$AMPH

Date	Price Target	Rating	Analyst
5/12/2025	$30.00	Overweight → Neutral	Analyst
2/4/2025	$66.00 → $36.00	Overweight → Neutral	Piper Sandler
11/22/2024	$55.00	Equal Weight	Wells Fargo
3/5/2024	$60.00	Overweight	JP Morgan
11/17/2023	$63.00	Neutral	BofA Securities
7/25/2023	$70.00	Buy	Jefferies
10/21/2022	$36.00	Buy	Jefferies
7/29/2022	$44.00	Overweight	CapitalOne